← Leaderboards
John D Mountz
University Of Alabama At Birmingham
$13,511,254
Attributed
$13,511,254
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,331,564 · 14
VA$0 · 4
By mechanism
R01$11,088,260 · 6
P30$6,586,827 · 6
T32$1,328,726 · 1
N01$327,751 · 1
I01$0 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Susan L Bellis$9,674,683
- Laurie Ellen Harrington$7,644,877
- Karin Marie Hardiman$2,227,249
- Hui-Chen Hsu$1,809,275
- Michael Marciel$209,964
Others in their field
Top investigators on “Systemic Lupus Erythematosus”
- Ignacio E. Sanz · University Of Rochester$57,737,718
- George C Tsokos · Beth Israel Deaconess Medical Center$37,219,358
- David Wofsy · University Of California, San Francisco$36,472,228
- Betty Diamond · Feinstein Institute For Medical Research$32,406,714
- John Barker Harley · Cincinnati Va Medical Center Research$30,355,689
- Patrick M Gaffney · University Of Minnesota Twin Cities$27,964,103
Research focus
Systemic Lupus ErythematosusCellsEventSignal TransductionB-LymphocytesPlayProductionLupusMediatingResponseIn VivoAutoantibodiesPathway InteractionsGenesMouse ModelPhenotypeAutoimmune DiseasesInterferonsPathogenesisAutoimmunityTechnologyExhibitsImmuneInterferon Type I
Grant awards (74)
AhR suppression of T-bet+ B cells in SLE$555,774
R01 · FY2025 · AI · contact PI
Training Program in Rheumatic and Musculoskeletal Diseases Research$266,003
T32 · FY2025 · AR · contact PI
Cytokine-mediated B-cell development in lupus$0
I01 · FY2025 · VA · contact PI
Training Program in Rheumatic and Musculoskeletal Diseases Research$366,007
T32 · FY2024 · AR · contact PI
Cytokine-mediated B-cell development in lupus$0
I01 · FY2024 · VA · contact PI
Training Program in Rheumatic and Musculoskeletal Diseases Research$354,214
T32 · FY2023 · AR · contact PI
B-cell innate and adaptive protective immunity to SARS-CoV-2$0
I01 · FY2023 · VA · contact PI
Cytokine-mediated B-cell development in lupus$0
I01 · FY2023 · VA · contact PI
B cell intrinsic interferon-beta regulates autoreactive B cell development$471,309
R01 · FY2022 · AI · contact PI
Interferon Beta Initiated Development of Immunogenic T1 B cells in Lupus$0
I01 · FY2022 · VA · contact PI
B-cell innate and adaptive protective immunity to SARS-CoV-2$0
I01 · FY2022 · VA · contact PI
B cell intrinsic interferon-beta regulates autoreactive B cell development$496,225
R01 · FY2021 · AI · contact PI
B-cell innate and adaptive protective immunity to SARS-CoV-2$0
I01 · FY2021 · VA · contact PI
Interferon Beta Initiated Development of Immunogenic T1 B cells in Lupus$0
I01 · FY2021 · VA · contact PI
B cell intrinsic interferon-beta regulates autoreactive B cell development$487,058
R01 · FY2020 · AI · contact PI
Training Program in Rheumatic and Musculoskeletal Diseases Research$342,502
T32 · FY2020 · AR · contact PI
Interferon Beta Initiated Development of Immunogenic T1 B cells in Lupus$0
I01 · FY2020 · VA · contact PI
B cell intrinsic interferon-beta regulates autoreactive B cell development$487,058
R01 · FY2019 · AI · contact PI
Interferon Beta Initiated Development of Immunogenic T1 B cells in Lupus$0
I01 · FY2019 · VA · contact PI
B cell intrinsic interferon-beta regulates autoreactive B cell development$414,400
R01 · FY2018 · AI · contact PI
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies$367,500
R01 · FY2018 · AI · contact PI
Interferon Beta Initiated Development of Immunogenic T1 B cells in Lupus$0
I01 · FY2018 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$586,550
P30 · FY2017 · AR · contact PI
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies$367,500
R01 · FY2017 · AI · contact PI
Btk breaks the tolerance of marginal zone macrophages to apoptotic antigens$0
I01 · FY2017 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$586,550
P30 · FY2016 · AR · contact PI
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies$367,500
R01 · FY2016 · AI · contact PI
Btk breaks the tolerance of marginal zone macrophages to apoptotic antigens$0
I01 · FY2016 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$586,550
P30 · FY2015 · AR · contact PI
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies$367,500
R01 · FY2015 · AI · contact PI
Btk breaks the tolerance of marginal zone macrophages to apoptotic antigens$0
I01 · FY2015 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$586,550
P30 · FY2014 · AR · contact PI
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies$367,500
R01 · FY2014 · AI · contact PI
Comprehensive Flow Cytometry Core$178,788
P30 · FY2014 · AR · contact PI
Btk breaks the tolerance of marginal zone macrophages to apoptotic antigens$0
I01 · FY2014 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$560,493
P30 · FY2013 · AR · contact PI
Comprehensive Flow Cytometry Core$169,138
P30 · FY2013 · AR · contact PI
Regulation of Migration of Autoreactive Germinal Centers and Precursor B Cells$0
I01 · FY2013 · VA · contact PI
Rheumatic Diseases Core Centers (P30)$593,618
P30 · FY2012 · AR · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$355,286
R01 · FY2012 · AI · contact PI
Comprehensive Flow Cytometry Core$177,537
P30 · FY2012 · AR · contact PI
Regulation of Migration of Autoreactive Germinal Centers and Precursor B Cells$0
I01 · FY2012 · VA · contact PI
Rheumatic Diseases Core Center$579,999
P30 · FY2011 · AR · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$355,286
R01 · FY2011 · AI · contact PI
ROS Modulation of Innate and Adaptive Immunity in RA$54,049
P30 · FY2011 · AR · contact PI
Role of ST6Gal I-Mediated Receptor Sialylation in Autoimmune Disease$54,048
P30 · FY2011 · AR · contact PI
Epigenetics of Lupus$46,707
P30 · FY2011 · AR · contact PI
Regulation of Migration of Autoreactive Germinal Centers and Precursor B Cells$0
I01 · FY2011 · VA · contact PI
Rheumatic Diseases Core Center$580,000
P30 · FY2010 · AR · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$358,875
R01 · FY2010 · AI · contact PI
Rheumatic Diseases Core Center$580,000
P30 · FY2009 · AR · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$364,660
R01 · FY2009 · AI · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$362,500
R01 · FY2009 · AI · contact PI
Regulation of Migration of Autoreactive Germinal Centers and Precursor B Cells$0
I01 · FY2009 · VA · contact PI
Rheumatic Diseases Core Center$580,000
P30 · FY2008 · AR · contact PI
Suppression of pathogenic autoantibodies in lupus by inhibition of AID$362,500
R01 · FY2008 · AI · contact PI
QTL Analysis of Atopic Dermatitis$25,000
P30 · FY2006 · AR · contact PI
DEFECTIVE FAS APOPTOSIS DURING AGING$251,125
R01 · FY2005 · AG
QTL Analysis of Atopic Dermatitis$25,000
P30 · FY2005 · AR
DEFECTIVE FAS APOPTOSIS DURING AGING$251,125
R01 · FY2004 · AG
QTL Analysis of Atopic Dermatitis$36,250
P30 · FY2004 · AR
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS$502,250
R01 · FY2003 · AI
DEFECTIVE FAS APOPTOSIS DURING AGING$251,125
R01 · FY2003 · AG
ABLATION OF IMMUNE RESPONSE TO ADENOVIRUS VECTORS$220,303
R01 · FY2003 · AI
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS$452,025
R01 · FY2002 · AI
DEFECTIVE FAS APOPTOSIS DURING AGING$251,125
R01 · FY2002 · AG
ABLATION OF IMMUNE RESPONSE TO ADENOVIRUS VECTORS$213,887
R01 · FY2002 · AI
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS$502,250
R01 · FY2001 · AI
DEFECTIVE FAS APOPTOSIS DURING AGING$251,125
R01 · FY2001 · AG
ABLATION OF IMMUNE RESPONSE TO ADENOVIRUS VECTORS$207,657
R01 · FY2001 · AI
DEFECTIVE FAS APOPTOSIS DURING AGING$121,975
R01 · FY2001 · AG
IN VIVO IMAGE ANALYSIS OF AUTOREACTIVE T CELLS$502,250
R01 · FY2000 · AI
GENE THERAPY TO CORRECT ARTHRITIS IN AUTOIMMUNE MICE$327,751
N01 · FY2000 · AR
ABLATION OF IMMUNE RESPONSE TO ADENOVIRUS VECTORS$201,607
R01 · FY2000 · AI